DailyDoctor Archive Specialties Get app
All neurology briefings

The edition · Neurology

Anti-CGRP antibodies in early pregnancy were linked to more miscarriage; propranolol was not

A claims cohort of women with migraine sharpens the contraception conversation before CGRP antibodies are started. Also: ofatumumab against ocrelizumab in a national MS registry, and which dissected cervical arteries heal by six months.

The edition in brief

In 7,579 US pregnancies among women with migraine, filled anti-CGRP monoclonal antibodies in early pregnancy were associated with a higher risk of spontaneous abortion than no exposure (adjusted HR 1.42, 95% CI 1.12–1.80; bias-adjusted 1.33), while propranolol was not (aHR 1.02). The study is observational and based on claims. In a Danish registry of 1,870 people with relapsing-remitting MS, ofatumumab was associated with a slightly higher annualised relapse rate than ocrelizumab (0.05 vs 0.03; rate ratio 1.65), with no significant difference in time to relapse, disability worsening, progression independent of relapse or MRI activity; both rates were very low. In 1,095 patients with stenosing cervical artery dissection, 57.9% had fully recanalised by six months; older age, diabetes, smoking and occlusion at presentation predicted incomplete recanalisation, and antiplatelet versus anticoagulant choice made no difference.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for neurology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free